bpc-157 clinical trials human 2025 BPC-157: What the Science Says (Zero Trials) dihexa clinical trials humans BPC
Description
Although they are marketed as next-generation biohacks and research chemicals, many peptides are not approved for human use and lack basic clinical testing
supplied lyophilised at 99% purity by HPLC
The injections are relatively painless, with most patients experiencing only a slight pinch at the injection site
However, DSIP has delayed effects, with some research administering doses hours before bed or even during the day with benefits extending to that night's sleep
Starting low and increasing provides more signal
If you notice changes in alcohol tolerance while using BPC-157, drink less, not more
